BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35068845)

  • 21.
    Nogueira AVB; Nokhbehsaim M; Damanaki A; Eick S; Kirschneck C; Schröder A; Jantsch J; Deschner J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Situ Anabolic Activity of Periodontal Pathogens Porphyromonas gingivalis and Filifactor alocis in Chronic Periodontitis.
    Spooner R; Weigel KM; Harrison PL; Lee K; Cangelosi GA; Yilmaz Ö
    Sci Rep; 2016 Sep; 6():33638. PubMed ID: 27642101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tobacco smoke exacerbates Filifactor alocis pathogenicity.
    Iskander MMZ; Lamont GJ; Tan J; Pisano M; Uriarte SM; Scott DA
    J Clin Periodontol; 2023 Jan; 50(1):121-130. PubMed ID: 36122937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analysis of classical and new putative periodontal pathogens in subgingival biofilm: a case-control study.
    Al-hebshi NN; Al-Alimi A; Taiyeb-Ali T; Jaafar N
    J Periodontal Res; 2015 Jun; 50(3):320-9. PubMed ID: 25040261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emerging oral pathogen, Filifactor alocis, extends the functional lifespan of human neutrophils.
    Miralda I; Vashishta A; Rogers MN; Lamont RJ; Uriarte SM
    Mol Microbiol; 2022 Jun; 117(6):1340-1351. PubMed ID: 35437843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of the additional use of subgingival air-polishing with erythritol powder in the treatment of periodontitis patients: a randomized controlled clinical trial. Part II: effect on sub-gingival microbiome.
    Mensi M; Caselli E; D'Accolti M; Soffritti I; Farina R; Scotti E; Guarnelli ME; Fabbri C; Garzetti G; Marchetti S; Sordillo A; Trombelli L
    Clin Oral Investig; 2023 Jun; 27(6):2547-2563. PubMed ID: 36538094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and immunostimulatory activity of extracellular vesicles from Filifactor alocis.
    Kim HY; Lim Y; An SJ; Choi BK
    Mol Oral Microbiol; 2020 Jan; 35(1):1-9. PubMed ID: 31675472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of Filifactor alocis in primary and in secondary endodontic infections: A molecular study.
    Gomes BPFA; Louzada LM; Almeida-Gomes RF; Pinheiro ET; Sousa ELR; Jacinto RC; Arruda-Vasconcelos R
    Arch Oral Biol; 2020 Oct; 118():104826. PubMed ID: 32707141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Filifactor alocis--a new emerging periodontal pathogen.
    Aruni AW; Mishra A; Dou Y; Chioma O; Hamilton BN; Fletcher HM
    Microbes Infect; 2015 Jul; 17(7):517-30. PubMed ID: 25841800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Filifactor alocis has virulence attributes that can enhance its persistence under oxidative stress conditions and mediate invasion of epithelial cells by porphyromonas gingivalis.
    Aruni AW; Roy F; Fletcher HM
    Infect Immun; 2011 Oct; 79(10):3872-86. PubMed ID: 21825062
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Aja E; Mangar M; Fletcher HM; Mishra A
    J Dent Res; 2021 Jul; 100(8):790-797. PubMed ID: 33719654
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of T CD4 lymphocyte levels and subgingival microbiota of chronic periodontitis in HIV-infected Brazilians under HAART.
    Gonçalves LS; Ferreira SM; Silva A; Villoria GE; Costinha LH; Souto R; Uzeda MD; Colombo AP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):196-203. PubMed ID: 14970778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation and quantification of key periodontal pathogens in patients with type 2 diabetes.
    Field CA; Gidley MD; Preshaw PM; Jakubovics N
    J Periodontal Res; 2012 Aug; 47(4):470-8. PubMed ID: 22220967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Subgingival Microbiome of Periodontal Pockets With Different Probing Depths in Chronic and Aggressive Periodontitis: A Pilot Study.
    Shi M; Wei Y; Hu W; Nie Y; Wu X; Lu R
    Front Cell Infect Microbiol; 2018; 8():124. PubMed ID: 29765908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new checkerboard panel for testing bacterial markers in periodontal disease.
    Dahlén G; Leonhardt A
    Oral Microbiol Immunol; 2006 Feb; 21(1):6-11. PubMed ID: 16390335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of three putative periodontal pathogens with chronic periodontitis in Brazilian subjects.
    Gonçalves C; Soares GM; Faveri M; Pérez-Chaparro PJ; Lobão E; Figueiredo LC; Baccelli GT; Feres M
    J Appl Oral Sci; 2016 Apr; 24(2):181-5. PubMed ID: 27119767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial profile of patients with periodontitis compared with healthy subjects.
    Stingu CS; Jentsch H; Eick S; Schaumann R; Knöfler G; Rodloff A
    Quintessence Int; 2012 Feb; 43(2):e23-31. PubMed ID: 22257880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Filifactor alocis manipulates human neutrophils affecting their ability to release neutrophil extracellular traps induced by PMA.
    Armstrong CL; Klaes CK; Vashishta A; Lamont RJ; Uriarte SM
    Innate Immun; 2018 May; 24(4):210-220. PubMed ID: 29649915
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Ozuna H; Snider I; Belibasakis GN; Oscarsson J; Johansson A; Uriarte SM
    Front Oral Health; 2022; 3():981343. PubMed ID: 36046121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between periodontitis-associated subgingival microbiota and clinical inflammation by 16S pyrosequencing.
    Camelo-Castillo A; Novoa L; Balsa-Castro C; Blanco J; Mira A; Tomás I
    J Clin Periodontol; 2015 Dec; 42(12):1074-82. PubMed ID: 26461079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.